Cytokinetics (CYTK) P/S ratio

P/S ratio today
70.5×

Cytokinetics (CYTK) trades at 70.5× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 86.7×. That is 69.6% lower than the 285.1× of fiscal 2024. Figures as of 18 Nov 2026, 10:32 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio today
70.5×
P/S ratio, fiscal 2025
86.7×
Change on fiscal 2024
−69.6%
Highest on record
285.1×fiscal 2024
Lowest on record
2.1×fiscal 2009
Fiscal years on record
132009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Cytokinetics P/S ratio, in more detail

Today's figure is 18.7% below the fiscal 2025 year-end.

Across the 13 fiscal year-ends on record (2009–2025), the highest was 285.1× in fiscal 2024 and the lowest 2.1× in fiscal 2009. Today's P/S ratio is higher than at 85% of the 13 fiscal year-ends on record; their median is 24.1×.

History · 13 fiscal years

P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Cytokinetics P/S ratio, year by year

Cytokinetics (CYTK) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today70.5×—$51.65—
202586.7× 69.6% down$63.54$0.73
2024285.1×—$47.04$0.16
2023——$83.49$0.08
202243.5× 12.6% down$45.82$1.05
202149.8× 106.9% up$45.58$0.92
202024.1×—$20.78$0.86
2019——$10.61—
2018——$6.32—
201730.1× 519.8% up$8.15$0.27
20164.9× 65.7% down$12.15$2.50
201514.2× 132.5% up$10.46$0.74
20146.1×—$8.01$1.31
2013——$6.50—
20129.5× 44.2% down$3.96$0.42
201117.0× 67.3% down$5.76$0.34
201052.0× 2,415.7% up$12.54$0.24
20092.1×—$17.46$8.44
2008——$17.10—
2007——$28.38—
2006——$44.88—
2005——$39.12—
2004——$61.50—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

P/S ratio at health care companies of similar size

P/S ratio of Cytokinetics and comparable companies
CompanyP/S ratio
Alkermes ALKS5.2×
PACS Group PACS1.5×
Kiniksa Pharmaceuticals International KNSA11.0×
ImmunityBio IBRX58.8×
Cytokinetics CYTK81.7×

Today's market value divided by revenue for the latest fiscal year. A company whose statements are in another currency than its shares is left out.

More on CYTK

Cytokinetics, figure by figure

Cytokinetics (CYTK) overview: price, valuation and scorecardAll health care companies by market value

Cytokinetics P/S ratio: questions and answers

What is Cytokinetics's P/S ratio?

Cytokinetics (CYTK) trades at 70.5× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 86.7×. That is 69.6% lower than the 285.1× of fiscal 2024.

Is Cytokinetics's P/S ratio high or low compared with its own history?

Today's P/S ratio is higher than at 85% of the 13 fiscal year-ends on record; their median is 24.1×.

What are the highest and lowest P/S ratio figures on record for Cytokinetics?

Across the 13 fiscal year-ends on record (2009–2025), the highest was 285.1× in fiscal 2024 and the lowest 2.1× in fiscal 2009.

How is Cytokinetics's P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end. For Cytokinetics it is on record here for 13 fiscal years, 2009 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Cytokinetics (CYTK) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/CYTK/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.